$84.37
▲ +0.0% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 4
● 18
▼ 0
Edwards' Q2 Earnings on the Horizon: What's in the Cards?
Truist Adjusts Price Target on Edwards Lifesciences to $95 From $90, Maintains Hold Rating
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
Overview
52-week range
$72
$89
70% of range
Avg surprise (last 2)
+7.4%
Avg reaction (last 2)
-0.8%
0% positive
Latest IV / EM
39%
EM ±8.9% · $85 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.66 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.50 | — | — | — | — | financials |
| Thu Jul 24, 2025 | Jun/2025 | $0.67 | $0.62 | +8.1% | — | -1.4% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $0.64 | $0.60 | +6.7% | — | -0.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $5.13 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.61 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.58 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.63 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.50 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 23, 2026 | Jun/2026 | AMC | $0.73 | $0.67 | +9.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.65B | — | $1.55B | $1.53B | $1.41B | — | $1.35B | $1.37B |
| Cost of revenue | $363M | — | $345M | $344M | $302M | — | $263M | $276M |
| Gross profit | $1.29B | — | $1.21B | $1.19B | $1.11B | — | $1.09B | $1.09B |
| Operating income | $478M | — | $307M | $411M | $395M | — | $351M | $366M |
| Net income | $381M | — | $291M | $333M | $358M | — | $3.07B | $366M |
| EPS (diluted) | $0.66 | — | $0.50 | $0.56 | $0.61 | — | $5.13 | $0.61 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.45B | $2.94B | $2.69B | $3.27B | $3.14B | $3.05B | $3.68B | $1.64B |
| Inventory | $1.12B | $1.13B | $1.14B | $1.14B | $1.11B | $1.09B | $1.10B | $1.02B |
| Total current assets | $6.23B | $6.74B | $6.36B | $6.58B | $6.21B | $6.29B | $6.73B | $4.52B |
| Total assets | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B |
| Long-term debt | $598M | $598M | $598M | $598M | $598M | $598M | $598M | $597M |
| Total liabilities | $2.99B | $3.36B | $3.07B | $2.88B | $2.83B | $2.99B | $3.36B | $2.59B |
| Total equity | $10.33B | $10.34B | $10.21B | $10.55B | $10.13B | $10.00B | $9.55B | $7.44B |